Table 3.
Distribution of levels of other comorbidity measured by RUB (resource utilization band) in the study population
| Total | Patients without COPD | Patients with COPD | p value* | |||
|---|---|---|---|---|---|---|
| No heart failure | Heart failure | No heart failure | Heart failure | |||
| RUB 0 | 102,071 (32.51 %) | 101,835 (33.34 %) | 81 (1.65 %) | 150 (4.49 %) | 5 (0.71 %) | 0.000 |
| RUB 1 | 44,126 (14.05 %) | 43,855 (14.36 %) | 86 (1.78 %) | 181 (5.96 %) | 4 (0.57 %) | 0.001 |
| RUB 2 | 65,322 (20.8 %) | 64,533 (21.13 %) | 282 (5.83 %) | 481 (15.84 %) | 26 (3.71 %) | 0.000 |
| RUB 3 | 89,042 (28.36 %) | 84,602 (27.7 %) | 2514 (51.95 %) | 1603 (52.80 %) | 323 (46.14 %) | 0.000 |
| RUB 4 | 10,383 (3.31 %) | 10,383 (3.31 %) | 1234 (25.50 %) | 434 (14.30 %) | 203 (29 %) | 0.000 |
| RUB 5 | 3033 (0.97 %) | 2065 (0.68 %) | 642 (13.27 %) | 187 (6.16 %) | 139 (19.89 %) | 0.000 |
| Total | 313,977 (100 %) | 305,402 (100 %) | 4839 (100 %) | 3036 (100 %) | 700 (100 %) | 0.000 |
* p value describes differences between groups with and without COPD